To explore the hypothesis that dysregulated mitochondrial dynamics may impact drug sensitivity, we began by examining the alteration status of six canonical dynamics-regulating genes - OPA1, MFN1, MFN2, FIS1, MFF, and DNM1L (which encodes Drp1)—in human cancers. The gene discussed is MFN2; the disease is cancer.